DK174203B1 - Stabiliserede human-vævsplasminogenaktivator-præparater - Google Patents
Stabiliserede human-vævsplasminogenaktivator-præparater Download PDFInfo
- Publication number
- DK174203B1 DK174203B1 DK198606057A DK605786A DK174203B1 DK 174203 B1 DK174203 B1 DK 174203B1 DK 198606057 A DK198606057 A DK 198606057A DK 605786 A DK605786 A DK 605786A DK 174203 B1 DK174203 B1 DK 174203B1
- Authority
- DK
- Denmark
- Prior art keywords
- composition according
- concentration
- human tissue
- composition
- arginine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81108185 | 1985-12-17 | ||
US06/811,081 US4777043A (en) | 1985-12-17 | 1985-12-17 | Stabilized human tissue plasminogen activator compositions |
Publications (3)
Publication Number | Publication Date |
---|---|
DK605786D0 DK605786D0 (da) | 1986-12-16 |
DK605786A DK605786A (da) | 1987-06-18 |
DK174203B1 true DK174203B1 (da) | 2002-09-16 |
Family
ID=25205495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198606057A DK174203B1 (da) | 1985-12-17 | 1986-12-16 | Stabiliserede human-vævsplasminogenaktivator-præparater |
Country Status (23)
Country | Link |
---|---|
US (2) | US4777043A (fi) |
EP (1) | EP0228862B1 (fi) |
JP (2) | JPH0714886B2 (fi) |
KR (1) | KR950010322B1 (fi) |
AT (1) | ATE79273T1 (fi) |
AU (1) | AU600246B2 (fi) |
DD (1) | DD255477A5 (fi) |
DE (2) | DE3686410T2 (fi) |
DK (1) | DK174203B1 (fi) |
ES (1) | ES2044840T3 (fi) |
FI (1) | FI88873C (fi) |
FR (1) | FR2591485B1 (fi) |
GB (1) | GB2184354B (fi) |
GR (1) | GR3006078T3 (fi) |
HU (1) | HU200101B (fi) |
IE (1) | IE59060B1 (fi) |
IL (1) | IL80904A (fi) |
MY (1) | MY102185A (fi) |
NO (1) | NO168988C (fi) |
NZ (1) | NZ218612A (fi) |
PH (1) | PH24716A (fi) |
PT (1) | PT83933B (fi) |
ZA (1) | ZA869457B (fi) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE83153T1 (de) * | 1985-09-10 | 1992-12-15 | Eisai Co Ltd | Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung. |
JPH0672105B2 (ja) * | 1985-10-02 | 1994-09-14 | 持田製薬株式会社 | 血栓溶解剤及びその製法 |
US5453363A (en) * | 1985-10-23 | 1995-09-26 | Boehringer Mannheim Gmbh | Process for the activation of t-PA or Ing after genetic expression in prokaryotes |
US5034225A (en) * | 1985-12-17 | 1991-07-23 | Genentech Inc. | Stabilized human tissue plasminogen activator compositions |
JP2708749B2 (ja) | 1987-08-10 | 1998-02-04 | エーザイ株式会社 | 修飾型tPA含有注射用組成物 |
EP0317376B2 (fr) * | 1987-10-23 | 1996-04-03 | Centre Regional De Transfusion Sanguine De Lille | Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques |
US4898826A (en) * | 1987-12-10 | 1990-02-06 | Invitron Corporation | Method to solubilize tissue plasminogen activator |
HU206367B (en) * | 1988-04-30 | 1992-10-28 | Sandoz Ag | Process for producing acid addition salts of steroid carboxylic acid-amidated taurine and glycine, as well as pharmaceutical compositions comprising such salts |
US4980165A (en) * | 1989-01-27 | 1990-12-25 | Genetics Institute, Inc. | Pharmaceutical formulations of plasminogen activator proteins |
DE3903581A1 (de) * | 1989-02-07 | 1990-08-16 | Boehringer Mannheim Gmbh | Gewebs-plasminogenaktivator-derivat |
JP2520975B2 (ja) * | 1989-09-21 | 1996-07-31 | 三井東圧化学株式会社 | 組織プラスミノ―ゲンアクチベ―タ―若しくはその誘導体を含有する血栓溶解剤 |
US6207151B1 (en) * | 1989-09-21 | 2001-03-27 | Mitsui Chemicals Inc. | Aqueous solution of t-PA |
DE3942142A1 (de) * | 1989-12-20 | 1991-06-27 | Boehringer Mannheim Gmbh | Stabilisierung von glykosyliertem t-pa |
DE3942143A1 (de) * | 1989-12-20 | 1991-06-27 | Boehringer Mannheim Gmbh | T-pa pro stabilisierung |
DE3942144A1 (de) * | 1989-12-20 | 1991-06-27 | Boehringer Mannheim Gmbh | Stabilisierung von k1k2p pro |
DE3942145A1 (de) * | 1989-12-20 | 1991-06-27 | Boehringer Mannheim Gmbh | T-pa-solubilisierung |
DE3942141A1 (de) * | 1989-12-20 | 1991-06-27 | Boehringer Mannheim Gmbh | K2p pro-stabilisierung |
US5358708A (en) * | 1993-01-29 | 1994-10-25 | Schering Corporation | Stabilization of protein formulations |
US5656730A (en) * | 1995-04-07 | 1997-08-12 | Enzon, Inc. | Stabilized monomeric protein compositions |
DE19606551C2 (de) * | 1996-02-22 | 2000-06-08 | Basotherm Gmbh | rt-PA zur Prävention des Nachstars nach Kataraktoperation |
US5972912A (en) * | 1998-12-17 | 1999-10-26 | S.P. Pharmaceuticals | Method for lyophilizing ifosfamide |
ATE264340T1 (de) * | 1999-08-17 | 2004-04-15 | Novo Nordisk Healthcare Ag | Stabilisierung von gefriergetrocknetem kuchen |
US6586574B1 (en) | 1999-08-17 | 2003-07-01 | Nn A/S | Stabilization of freeze-dried cake |
SI1226269T1 (en) | 1999-11-04 | 2003-12-31 | Genentech, Inc. | Assay |
WO2001074397A1 (fr) * | 2000-03-31 | 2001-10-11 | Kirin Beer Kabushiki Kaisha | Preparation en poudre destinee a etre administree par les muqueuses comprenant un medicament de forme polymere et presentant une stabilite de conservation amelioree |
CN1553811A (zh) * | 2001-09-07 | 2004-12-08 | ӡ�����Ƽ��ɷ�����˾ | 人组织尿激酶类型纤溶酶原激活物制剂 |
US20110179558A1 (en) * | 2009-07-29 | 2011-07-28 | International Enviroguard Systems, Inc. | Breathable Protective Fabric and Garment |
US20140274873A1 (en) * | 2013-03-14 | 2014-09-18 | Allergan, Inc. | Composition of a sustained-release delivery and method of stabilizing proteins during fabrication process |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK98833C (da) * | 1961-04-25 | 1964-05-25 | Novo Terapeutisk Labor As | Fremgangsmåde til stabilisering af terapeutisk anvendelige plasminopløsninger. |
DE3273732D1 (en) * | 1982-12-30 | 1986-11-20 | Kowa Co | Method of producing a tissue plasminogen activator and composition comprising same |
JPS59196824A (ja) * | 1983-04-21 | 1984-11-08 | Kowa Co | 吸着防止剤 |
DE3584902D1 (de) * | 1984-02-29 | 1992-01-30 | Asahi Chemical Ind | Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren. |
EP0199574B1 (en) * | 1985-04-22 | 1991-10-23 | Genentech, Inc. | Human tissue plasminogen activator mutants, methods and intermediates therefor, and compositions using such mutants |
ES8706443A1 (es) * | 1985-05-28 | 1987-07-01 | Wellcome Found | Un procedimiento para preparar una solucion parenteral de activador de plasminogeno de tejido (t-pa) |
US4929444A (en) * | 1985-05-28 | 1990-05-29 | Burroughs Wellcome Co. | Low pH pharmaceutical formulation containing t-PA |
ZW14486A1 (en) * | 1985-07-29 | 1986-10-22 | Smithkline Beckman Corp | Pharmaceutical dosage unit |
ATE83153T1 (de) * | 1985-09-10 | 1992-12-15 | Eisai Co Ltd | Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung. |
JPH0672105B2 (ja) * | 1985-10-02 | 1994-09-14 | 持田製薬株式会社 | 血栓溶解剤及びその製法 |
DE3537708A1 (de) * | 1985-10-23 | 1987-04-23 | Boehringer Mannheim Gmbh | Verfahren zur aktivierung von t-pa nach expression in prokaryonten |
JPS62120321A (ja) * | 1985-11-20 | 1987-06-01 | Eisai Co Ltd | tPA含有医薬組成物 |
JPS62283932A (ja) * | 1986-05-29 | 1987-12-09 | Green Cross Corp:The | 組織プラスミノ−ゲンアクチベ−タの乾燥製剤 |
-
1985
- 1985-12-17 US US06/811,081 patent/US4777043A/en not_active Expired - Lifetime
-
1986
- 1986-12-08 IL IL80904A patent/IL80904A/xx not_active IP Right Cessation
- 1986-12-12 NZ NZ218612A patent/NZ218612A/xx unknown
- 1986-12-15 PT PT83933A patent/PT83933B/pt unknown
- 1986-12-16 AT AT86309811T patent/ATE79273T1/de not_active IP Right Cessation
- 1986-12-16 GB GB8629981A patent/GB2184354B/en not_active Revoked
- 1986-12-16 DE DE8686309811T patent/DE3686410T2/de not_active Expired - Lifetime
- 1986-12-16 ES ES86309811T patent/ES2044840T3/es not_active Expired - Lifetime
- 1986-12-16 AU AU66610/86A patent/AU600246B2/en not_active Expired
- 1986-12-16 DD DD86297695A patent/DD255477A5/de unknown
- 1986-12-16 NO NO865079A patent/NO168988C/no not_active IP Right Cessation
- 1986-12-16 FR FR8617593A patent/FR2591485B1/fr not_active Expired
- 1986-12-16 DE DE19863642960 patent/DE3642960A1/de not_active Ceased
- 1986-12-16 KR KR1019860010747A patent/KR950010322B1/ko not_active IP Right Cessation
- 1986-12-16 PH PH34602A patent/PH24716A/en unknown
- 1986-12-16 EP EP86309811A patent/EP0228862B1/en not_active Expired - Lifetime
- 1986-12-16 IE IE327986A patent/IE59060B1/en not_active IP Right Cessation
- 1986-12-16 DK DK198606057A patent/DK174203B1/da not_active IP Right Cessation
- 1986-12-16 HU HU865225A patent/HU200101B/hu unknown
- 1986-12-17 FI FI865159A patent/FI88873C/fi not_active IP Right Cessation
- 1986-12-17 JP JP61302767A patent/JPH0714886B2/ja not_active Expired - Lifetime
- 1986-12-17 ZA ZA869457A patent/ZA869457B/xx unknown
-
1987
- 1987-10-01 MY MYPI87002760A patent/MY102185A/en unknown
-
1988
- 1988-03-28 US US07/173,854 patent/US4908205A/en not_active Expired - Lifetime
-
1992
- 1992-10-26 GR GR920402407T patent/GR3006078T3/el unknown
-
1994
- 1994-08-04 JP JP6183274A patent/JPH07173076A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK174203B1 (da) | Stabiliserede human-vævsplasminogenaktivator-præparater | |
US7803911B2 (en) | Dried blood factor composition comprising trehalose | |
US7501493B2 (en) | Dried blood factor composition comprising trehalose | |
CA2171266C (en) | Stable transglutaminase preparations and processes for producing them | |
US8071090B2 (en) | Stabilized thrombin compositions | |
MX2011004861A (es) | Formulaciones del factor viii. | |
US5034225A (en) | Stabilized human tissue plasminogen activator compositions | |
US7244824B2 (en) | Dried blood factor composition comprising trehalose | |
JPH0424331B2 (fi) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PUP | Patent expired |